Acceleron Pharma Inc organizacji Net debt/EBITDA
Jaka jest wartość Net debt/EBITDA organizacji Acceleron Pharma Inc?
Wartość Net debt/EBITDA organizacji Acceleron Pharma Inc to 10.60
Jaka jest definicja Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA firm w Health Care sektor na NASDAQ w porównaniu do Acceleron Pharma Inc
Czym się zajmuję organizacja Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Firmy z net debt/ebitda podobne do Acceleron Pharma Inc
- Wartość Net debt/EBITDA organizacji GGL Resources to 10.59
- Wartość Net debt/EBITDA organizacji T-Mobile US to 10.59
- Wartość Net debt/EBITDA organizacji WorleyParsons to 10.59
- Wartość Net debt/EBITDA organizacji WorleyParsons to 10.59
- Wartość Net debt/EBITDA organizacji Colfax Corp to 10.59
- Wartość Net debt/EBITDA organizacji The Cooper Companies to 10.59
- Wartość Net debt/EBITDA organizacji Acceleron Pharma Inc to 10.60
- Wartość Net debt/EBITDA organizacji Faurecia S.E to 10.60
- Wartość Net debt/EBITDA organizacji Kellogg to 10.61
- Wartość Net debt/EBITDA organizacji Saputo to 10.61
- Wartość Net debt/EBITDA organizacji Aon plc to 10.62
- Wartość Net debt/EBITDA organizacji Olema Pharmaceuticals to 10.62
- Wartość Net debt/EBITDA organizacji RealPage to 10.63